Screener
Biogen BIIB Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Biogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
| (In millions) | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest income | $(25.3) | $(32.3) | $(63.2) | $(56.2) |
| Interest expense | 82.3 | 72.6 | 149.9 | 132.6 |
| (Gains) losses on investments, net | (41.6) | (5.3) | (63.9) | 30.3 |
| Litigation related expense | (0.4) | 5.2 | 4.3 | 8.2 |
| Foreign exchange (gains) losses, net | 6.5 | 10.4 | 13.0 | 6.6 |
| Other, net | (3.0) | (1.9) | (1.9) | (4.4) |
| Total other (income) expense, net | $18.5 | $48.7 | $38.2 | $117.1 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Biogen's interest income?
- Biogen (BIIB) reported interest income of $25.3M in Q2 2026.
- How has Biogen's interest income changed year-over-year?
- Biogen's interest income decreased by 21.7% year-over-year, from $32.3M to $25.3M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Biogen's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude